ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Heather Hampel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7558-9794; OpenAlex author ID A5012798070. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jessica N. Everett · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Elana Levinson · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Marta Puzzono · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Eve Karloski · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Beth Dudley · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Christine M. Drogan · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Giulia Martina Cavestro · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Diane M. Simeone · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Randall E. Brand · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Sonia S. Kupfer · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Fay Kastrinos · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Sameek Roychowdhury · 1 shared paper, 2023 · strength 0.14
- Paper Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. DOI 10.1007/s10689-022-00300-5 ↗
Mitchell L. Ramsey · 1 shared paper, 2023 · strength 0.14
- Paper Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. DOI 10.1007/s10689-022-00300-5 ↗
Laith I. Abushahin · 1 shared paper, 2023 · strength 0.14
- Paper Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. DOI 10.1007/s10689-022-00300-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.